Olmesartan Medoxomil 40mg + Chlorthalidone 12.5mg Tablet Franchise in Ahmedabad

Blood Pressure Control Tablet Supplier in Mumbai

Antihypertensive Medicine Distributor in Delhi

Cardiology Tablet Franchise Opportunity in Bangalore

Hypertension Medicine Stockist in Hyderabad
Olmesartan Chlorthalidone Tablet Manufacturer & Exporter in Chandigarh

Home/Products /olmesartan-medoxomil-40-mg-chlorthalidone-12-5-mg-tablet

About the Product

Description


Olmeslide CH 40 Tablet is formulated with Olmesartan Medoxomil 40mg and Chlorthalidone 12.5mg, a powerful antihypertensive combination that helps in the effective control of high blood pressure. This dual-action therapy supports sustained blood pressure reduction and minimizes cardiovascular complications.

Olmesartan Medoxomil is an angiotensin II receptor blocker (ARB) that relaxes blood vessels and improves blood flow, while Chlorthalidone is a long-acting thiazide-like diuretic that helps eliminate excess salt and water from the body. Together, they provide enhanced and long-lasting antihypertensive control.

This combination is widely prescribed for patients who do not achieve adequate blood pressure control with monotherapy. It is suitable for long-term hypertension management and is commonly used in cardiology and internal medicine practice.

Adding Olmeslide CH 40 Tablet to your cardiology and antihypertensive segment strengthens your product portfolio with a high-demand, clinically trusted combination. It offers excellent opportunities across hospital supply, retail distribution, institutional tenders, export markets, and third-party manufacturing.

Some patients may experience dizziness, headache, fatigue, increased urination, or electrolyte imbalance. Rarely, hypotension, dehydration, or renal function changes may occur.

Olmeslide CH 40 Tablet is formulated with Olmesartan Medoxomil 40mg and Chlorthalidone 12.5mg, a powerful antihypertensive combination that helps in the effective control of high blood pressure. This dual-action therapy supports sustained blood pressure reduction and minimizes cardiovascular complications. Olmesartan Medoxomil is an angiotensin II receptor blocker (ARB) that relaxes blood vessels and improves blood flow, while Chlorthalidone is a long-acting thiazide-like diuretic that helps eliminate excess salt and water from the body. Together, they provide enhanced and long-lasting antihypertensive control. This combination is widely prescribed for patients who do not achieve adequate blood pressure control with monotherapy. It is suitable for long-term hypertension management and is commonly used in cardiology and internal medicine practice. Adding Olmetyle C 40 Tablet to your cardiology and antihypertensive segment strengthens your product portfolio with a high-demand, clinically trusted combination. It offers excellent opportunities across hospital supply, retail distribution, institutional tenders, export markets, and third-party manufacturing.

Use under medical supervision. Regular monitoring of blood pressure, kidney function, and electrolytes is recommended. Caution is advised in patients with renal impairment, dehydration, or electrolyte disturbances.

Store Olmeslide CH 40 Tablet in a cool, dry place below 25°C, away from light and moisture. Keep out of reach of children.

Get in Touch

Regulatory Compliance & Professional Verification

This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.

  • No Consumer Sale: We do not entertain retail inquiries or direct sales to patients.
  • Information Accuracy: While we strive for accuracy, product availability, packaging, and regulatory status may change based on CDSCO guidelines and state-specific drug laws.
  • Medical Advice: Patients are strictly advised not to self-medicate or use this information for treatment. Always consult a qualified medical practitioner.
  • Licensing: All business associations are subject to the submission of valid GST and Drug License (DL) documentation.

Frequently Asked Questions

What are the business opportunities for Olmesartan Medoxomil 40mg + Chlorthalidone 12.5mg Tablet in the PCD pharma franchise market?

Olmesartan Medoxomil 40mg + Chlorthalidone 12.5mg Tablet has strong demand in the cardiology, hypertension, and chronic disease management segment, making it a valuable product for medical distributors, wholesalers, and pharma franchise partners focusing on advanced antihypertensive therapy portfolios.

Why should medical distributors include this tablet in their product range?

Medical distributors and agencies can benefit from consistent demand for moderate to severe hypertension management under long-term medical supervision. Olmesartan Medoxomil 40mg is an angiotensin II receptor blocker (ARB) that helps relax blood vessels and lower blood pressure Chlorthalidone 12.5mg is a diuretic that helps remove excess fluid and enhances blood pressure control Commonly prescribed for stage 1 and stage 2 hypertension, resistant hypertension, and patients requiring combination therapy for BP control Helps reduce risk of cardiovascular complications such as stroke, heart attack, and kidney damage Widely prescribed by cardiologists, physicians, and general practitioners This strengthens a comprehensive cardiovascular and antihypertensive portfolio.

Does Cafoli LifeCare Pvt Ltd offer PCD pharma franchise opportunities for this product?

Yes, Cafoli LifeCare Pvt Ltd offers PCD pharma franchise opportunities for Olmesartan Medoxomil + Chlorthalidone Tablet with promotional support, monopoly rights, attractive packaging, and competitive pricing for distributors and wholesalers.

What benefits do wholesalers get by partnering for this product?

Wholesalers and medical agencies benefit from strong chronic prescription demand, long-term therapy usage, repeat orders, reliable supply chain support, and attractive margins in the cardiology segment.

How can I become a distributor or franchise partner for this product?

Interested distributors, stockists, and wholesalers can partner with Cafoli LifeCare Pvt Ltd to access lucrative PCD pharma franchise opportunities across India. With exclusive monopoly rights, extensive promotional support, high-quality product ranges, attractive business margins, and dependable logistics support, Cafoli LifeCare Pvt Ltd helps franchise partners build a successful and profitable pharmaceutical business.